High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Clinical trial NCT02860039 · COMPLETED

Trial details

NCT number: NCT02860039
Sponsor: Vanderbilt-Ingram Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematopoietic Cell Transplantation Recipient Malignant Neoplasm Influenza

Start date: 2016-09-01
Primary completion: 2021-12-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.